Narayana Hrudayalaya Limited Stock

Equities

NH

INE410P01011

Healthcare Facilities & Services

Market Closed - NSE India S.E. 07:43:53 2024-05-31 am EDT 5-day change 1st Jan Change
1,189 INR +1.86% Intraday chart for Narayana Hrudayalaya Limited -5.07% -1.06%
Sales 2024 50.18B 602M Sales 2025 * 57.74B 692M Capitalization 242B 2.9B
Net income 2024 7.89B 94.63M Net income 2025 * 7.87B 94.34M EV / Sales 2024 5.2 x
Net Debt 2024 * 3.63B 43.57M Net Debt 2025 * 6.54B 78.44M EV / Sales 2025 * 4.3 x
P/E ratio 2024
33 x
P/E ratio 2025 *
30.9 x
Employees 11,923
Yield 2024 *
0.15%
Yield 2025 *
0.1%
Free-Float 33.23%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.86%
1 week-5.07%
1 month-7.60%
3 months-11.38%
6 months-2.97%
Current year-1.06%
More quotes
1 week
1 121.00
Extreme 1121
1 270.75
1 month
1 121.00
Extreme 1121
1 311.00
Current year
1 121.00
Extreme 1121
1 444.90
1 year
895.00
Extreme 895
1 444.90
3 years
444.20
Extreme 444.2
1 444.90
5 years
200.05
Extreme 200.05
1 444.90
10 years
182.80
Extreme 182.8
1 444.90
More quotes
Managers TitleAgeSince
Chief Executive Officer - 19-02-02
Director of Finance/CFO - 21-12-07
Chief Operating Officer - 01-07-31
Members of the board TitleAgeSince
Director/Board Member 71 -
Founder 71 00-07-18
Director/Board Member 47 23-03-28
More insiders
Date Price Change Volume
24-05-31 1,189 +1.86% 636,124
24-05-30 1,168 +1.69% 718,991
24-05-29 1,148 -3.59% 539,822
24-05-28 1,191 -3.71% 478,623
24-05-27 1,237 -1.28% 251,835

Delayed Quote NSE India S.E., May 31, 2024 at 07:43 am EDT

More quotes
Narayana Hrudayalaya Limited is an India-based healthcare service provider, operating a chain of multispecialty, tertiary, and primary healthcare facilities. The Company is primarily engaged in the business of rendering medical and healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations. The Company owns and operates certain hospitals. Its medical services include anesthesia, blood bank, bone marrow transplant (stem cell transplant), breast cancer, electrophysiology, emergency medicine, endocrinology, family medicine, gastrointestinal oncology, general surgery, geriatrics, gynecology - oncology, pulmonology, radiation oncology, hematology, heart transplant, hepatology liver transplantation and infectious diseases. The Company has a network of approximately 19 hospitals and three heart centers across India along with overseas presence at Cayman Islands, with over 5,860 operational beds and a capacity of over 6,160 beds.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
1,189 INR
Average target price
1,367 INR
Spread / Average Target
+14.94%
Consensus